Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
The Data: The oral version showed promising speed, helping patients lose 12% of their body weight in just 13 weeks
Retatrutide Research Grade Peptide
You face excessive priorauthorization hurdles or are relegated to non-preferred tiers
The Oral GLP-1 Agonists Market is segmented as follows: By Product Semaglutide Tirzepatide Dulaglutide Liraglutide Others By Application Type 2 Diabetes Mellitus Obesity / Chronic Weight Management Cardiovascular Risk By Route of Administration Injectable / Parenteral Oral Regional Coverage: North America U.S
US$ 21.50
US$ 24.69
US$ 26.50
US$ 28.14
